<DOC>
	<DOCNO>NCT00000844</DOCNO>
	<brief_summary>To evaluate effect three preparation low-dose oral interferon alpha ( i.e. , Alferon LDO , Veldona , Ferimmune ) HIV symptoms HIV-infected patient . To evaluate difference response oral interferon alpha accord gender , race/ethnicity , use antiretrovirals . Previous ongoing clinical trial test efficacy low-dose oral interferon alpha produce different result , clear whether difference due interferon alpha product use problem study design . Therefore , three preparation compare evaluate potential efficacy .</brief_summary>
	<brief_title>A Multicenter , Prospective , Randomized , Double-Blind , Placebo-Controlled Trial Three Preparations Low-Dose Oral Alpha Interferon HIV-Infected Patients With CD4+ Counts &gt; = 50 &lt; = 350 Cells/mm3</brief_title>
	<detailed_description>Previous ongoing clinical trial test efficacy low-dose oral interferon alpha produce different result , clear whether difference due interferon alpha product use problem study design . Therefore , three preparation compare evaluate potential efficacy . Patients randomize receive 6 month Alferon LDO alone , Alferon Veldona , Alferon Ferimmune , three placebo , follow-up visit monthly .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Inclusion Criteria Patients must : Symptomatic HIV infection . CD4 count 50 350 cells/mm3 . Prior Medication : Allowed : Prior antiretrovirals ( dose must stable least 6 week prior study entry ) . Maintenance therapy chronic condition . Exclusion Criteria Patients follow prior condition exclude : Change antiretroviral therapy within past 6 week . Prior Medication : Excluded : Oral IFNalpha immunebased therapy within past month . Therapy acute disease within past week .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Adjuvants , Immunologic</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Interferon-alpha</keyword>
</DOC>